Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N ROWE

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|March 19, 2010
Intracranial tumors in childrenS N ROWE
Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists|October 8, 2004
The wrickkened pathways of FGF23, MEPE and PHEXPeter S N Rowe
Cell Biochemistry and Function|May 11, 2012
The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambledPeter S N Rowe
Critical Reviews in Eukaryotic Gene Expression|February 21, 2012
Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathwayPeter S N Rowe
Bone|June 9, 2015
Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motifLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Bone|December 3, 2014
SPR4-peptide alters bone metabolism of normal and HYP miceLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Plos One|May 21, 2014
PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolismLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Endocrinology|June 13, 2009
Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulatorValentin David, Aline Martin, Anne-Marie Hedge, et al.
British Journal of Cancer|February 11, 2010
MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducersP Zhang, H Wang, P S N Rowe, et al.
The Journal of Endocrinology|December 14, 2004
Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and ricketsDoron Bresler, Jan Bruder, Klaus Mohnike, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|March 19, 2010
Intracranial tumors in childrenS N ROWE
Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists|October 8, 2004
The wrickkened pathways of FGF23, MEPE and PHEXPeter S N Rowe
Cell Biochemistry and Function|May 11, 2012
The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambledPeter S N Rowe
Critical Reviews in Eukaryotic Gene Expression|February 21, 2012
Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathwayPeter S N Rowe
Bone|June 9, 2015
Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motifLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Bone|December 3, 2014
SPR4-peptide alters bone metabolism of normal and HYP miceLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Plos One|May 21, 2014
PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolismLesya V Zelenchuk, Anne-Marie Hedge, Peter S N Rowe
Endocrinology|June 13, 2009
Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulatorValentin David, Aline Martin, Anne-Marie Hedge, et al.
British Journal of Cancer|February 11, 2010
MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducersP Zhang, H Wang, P S N Rowe, et al.
The Journal of Endocrinology|December 14, 2004
Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and ricketsDoron Bresler, Jan Bruder, Klaus Mohnike, et al.
Pageof 3